Anthropic Is Aiming for the Biggest IPO Ever -- Here's the Chip Stock to Buy Before It Lists

Broadcom reportedly agreed to provide Anthropic up to $42 billion in convertible-note financing, against Anthropic’s five-year $125.2 billion computing-capacity lease commitment; Broadcom expects Anthropic to become its largest custom-chip customer in 2027. Broadcom’s fiscal Q3 2026 AI semiconductor revenue rose 221% year over year to $16.7 billion, and management forecast fiscal Q4 AI revenue of $21.7 billion, up 236%. The growth opportunity is offset by financing exposure and rising customer concentration: the top five end customers represented about 55% of fiscal Q3 revenue, versus 40% a year earlier.

Analysis

Broadcom’s exposure is not simply a large customer win: it is a supplier financing demand whose repayment capacity is linked to that same customer’s ability to raise capital and monetize compute. That can pull forward deployments while masking end-demand quality. The outside debt reportedly being arranged may distribute funding, but Broadcom’s lease backstop leaves residual downside; the stated facility is not equivalent to booked revenue or cash collected. Higher customer concentration makes any deployment delay a revenue, working-capital and credit-risk event at once.

Near term, the IPO filing can support sentiment, but the raise is neither completed nor necessarily available to repay Broadcom. Over the next 1–3 months, focus on actual debt issuance and terms, any prospectus detail on proceeds and convertible-note treatment, and Broadcom’s reported AI revenue versus customer concentration. Over 6–18 months, the thesis requires TPU capacity to be deployed and monetized without expanding financing exposure faster than cash receipts. A successful IPO could improve Anthropic’s funding access, but does not by itself eliminate Broadcom’s guarantees or conflicts-of-interest risk.

Contrarian read: the market may treat the financing as demand validation; it is also evidence that customer financing is part of the demand engine. The key missing data are the facility’s draw schedule, recourse and collateral, lease payment timing, and Broadcom’s maximum aggregate exposure across customers. Any premium for AI growth should be discounted for correlated customer/credit concentration. The IPO-size comparison with SpaceX does not establish comparable demand or funding certainty.

Key Decisions for Investors

• Do not treat the reported $42 billion facility or Anthropic’s prospective IPO proceeds as incremental Broadcom revenue. Before adding AVGO, verify facility terms, draw status, recourse, and whether proceeds can materially reduce Broadcom-backed exposure.
• For investors seeking AI exposure, favor a staged AVGO position rather than chasing the IPO-related narrative; pair it with a beta-adjusted short in a semiconductor ETF to reduce broad chip-cycle risk. Reassess after Broadcom reports AI revenue, customer concentration, and cash conversion.
• Use the next filing or earnings report as the 1–3 month catalyst check: strengthen the thesis only if deployments translate into recognized revenue and cash receipts without a disproportionate rise in guarantees or receivables. Cut or hedge if deployment timing slips, concentration worsens, or financing terms leave Broadcom with greater-than-expected recourse.
• Treat Anthropic’s IPO as an alert, not a de-risking catalyst, until proceeds, timing, and use of funds are disclosed. No actionable inference for SPCX follows from its mention as an IPO-size comparison.